Clinical Isolates of Aspergillus Species Remain Fully Susceptible to Voriconazole in the Post-Voriconazole Era
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00629-08
Full Text
Open PDFAbstract
Available in full text
Date
July 7, 2008
Authors
Publisher
American Society for Microbiology